NIH-funded research U01 cooperative agreement

Type 1 Diabetes after Acute Pancreatitis: Immune Clues from the Pacific Northwest

Official title: Type 1 Diabetes in Acute Pancreatitis Consortium – Pacific Northwest Clinical Center: Immune Pathogenesis of Post-Pancreatitis T1D

Funded at Benaroya Research Inst at Virginia Mason · NIH-11413767 · Data updated 2026-11-12

A multi-center study follows adults after an acute pancreatitis episode to understand how some develop Type 1 diabetes and what immune factors are involved.

More Diabetes research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionBenaroya Research Inst at Virginia Mason
NIH-funded
Lab location1 site (Seattle, United States)
Project startSeptember 16, 2020
Project endJuly 31, 2030
Funding year2026
Award (this year)$517,100
NIH project number5U01DK127404-07
Project IDNIH-11413767 on NIH RePORTER

Who could benefit from this research

Could help

Adults with a history of acute pancreatitis who are at risk for or concerned about developing Type 1 diabetes.

Less likely to help

People without a history of pancreatitis or diabetes are unlikely to benefit from this study.

What this research studies

This project tracks adults who have had acute pancreatitis over time to see how many develop diabetes and which type they get. It uses modern immune profiling to identify immune system patterns that may signal progression to Type 1 diabetes after pancreatitis. Researchers will collect clinical data, blood samples, and endocrine measurements to map risks and immune changes. The goal is to better predict who is at risk and to reveal potential targets for prevention or treatment.

Why it matters

Potential benefit: If successful, patients who have had pancreatitis could receive earlier risk assessment and new approaches to prevent or manage Type 1 diabetes after an pancreatitis episode.

How similar studies have gone: Previous work has suggested immune factors influence diabetes after pancreatitis, but this study aims for prospective, detailed immune profiling in a large cohort.

Where this research is happening

  • Benaroya Research Inst at Virginia Mason
    Seattle, United States
    Active

Researchers

  • Principal investigator: Speake, Cate — Benaroya Research Inst at Virginia Mason
  • Study coordinator: Speake, Cate

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.